S100A8 and inflammatory bowel disease: Teplar et al. used a random effects model and showed that the incidence of IBD, especially CD was significantly reduced in CagA seropositive patients, while the exposure of CagA seronegative H. pylori was not significantly associated with the incidence of IBD [15].